Moon Surgical's Maestro™ Robotic Surgery System Earns FDA Breakthrough Designation

Moon Surgical's Maestro surgical system has received FDA clearance, positioning it as a new entrant in the robotic surgery sector tailored for laparoscopic procedures. 

The system aims to enhance surgical capabilities through integrated AI algorithms powered by NVIDIA Holoscan, facilitating real-time data insights and precision during operations.

The system utilizes NVIDIA Holoscan AI algorithms to provide real-time data insights, helping surgeons make informed decisions and perform procedures with greater accuracy.
As a new entrant in the robotic surgery sector, Maestro underscores advancements in laparoscopic procedures, leveraging AI to improve surgical outcomes.

With successful CE mark approval and initial use in Europe across general, bariatric, and gynecologic surgeries, Maestro is now poised for a Limited Market Release in the United States, promising to optimize surgical efficiency and patient outcomes.

The Company commitment to innovation is underscored by Maestro's integration of NVIDIA Holoscan technology, which not only supports real-time imaging and data processing but also lays the groundwork for future advancements in robotic-assisted surgery. 

With its versatile application in laparoscopic settings, Maestro holds promise for improving patient outcomes and setting new standards in surgical care through its advanced technological capabilities and regulatory approvals across major global markets.

Source: https://www.prnewswire.com/news-releases/moon-surgical-receives-second-fda-clearance-covering-its-commercial-maestro-robotic-surgery-system-302164186.html